Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$483.12 USD
+2.03 (0.42%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $483.11 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ISRG 483.12 +2.03(0.42%)
Will ISRG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ISRG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ISRG
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
ISRG's Gross Margin Falls on Product Transition and Trade Pressures
ISRG: What are Zacks experts saying now?
Zacks Private Portfolio Services
EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down
Can ISRG's Strong Q2 Procedure Volume Translate Into Durable EPS Upside?
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
Other News for ISRG
Franklin U.S. Focused Growth SMA Q2 2025 Commentary
Franklin DynaTech SMA Q2 2025 Commentary
BME: The Resilient Income Investment Of The Healthcare Industry
Intuitive Surgical (ISRG) Shares Dip Despite Strong Q2 Performance
12 out of 12 healthcare firms top revenue estimates this week: Earnings Scorecard